Stebėti
Maximilian CCJC Ebert
Maximilian CCJC Ebert
Congruence Therapeutics
Patvirtintas el. paštas umontreal.ca
Pavadinimas
Cituota
Cituota
Metai
Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
V Mody, J Ho, S Wills, A Mawri, L Lawson, MC Ebert, GM Fortin, ...
Communications biology 4 (1), 93, 2021
2512021
Roles of TRPM2 in oxidative stress
N Takahashi, D Kozai, R Kobayashi, M Ebert, Y Mori
Cell calcium 50 (3), 279-287, 2011
2002011
Computational tools for enzyme improvement: why everyone can–and should–use them
MC Ebert, JN Pelletier
Current opinion in chemical biology 37, 89-96, 2017
1142017
Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro
DSM Lewis, J Ho, S Wills, A Kawall, A Sharma, K Chavada, MC Ebert, ...
Scientific reports 12 (1), 2145, 2022
392022
O2-dependent protein internalization underlies astrocytic sensing of acute hypoxia by restricting multimodal TRPA1 channel responses
M Uchiyama, A Nakao, Y Kurita, I Fukushi, K Takeda, T Numata, HN Tran, ...
Current Biology 30 (17), 3378-3396. e7, 2020
352020
Enzyme engineering: A synthetic biology approach for more effective library generation and automated high-throughput screening
D Quaglia, MC Ebert, PF Mugford, JN Pelletier
PLoS One 12 (2), e0171741, 2017
352017
Transnitrosylation directs TRPA1 selectivity in N-nitrosamine activators
D Kozai, Y Kabasawa, M Ebert, S Kiyonaka, Y Otani, T Numata, ...
Molecular pharmacology 85 (1), 175-185, 2014
342014
Fragment-based design of symmetrical bis-benzimidazoles as selective inhibitors of the trimethoprim-resistant, type II R67 dihydrofolate reductase
D Bastien, MC Ebert, D Forge, J Toulouse, N Kadnikova, F Perron, ...
Journal of Medicinal Chemistry 55 (7), 3182-3192, 2012
342012
AMBER free energy tools: a new framework for the design of optimized alchemical transformation pathways
HC Tsai, TS Lee, A Ganguly, TJ Giese, MC Ebert, P Labute, KM Merz Jr, ...
Journal of chemical theory and computation 19 (2), 640-658, 2023
282023
Monitoring protein conformational changes using fluorescent nanoantennas
SG Harroun, D Lauzon, MC Ebert, A Desrosiers, X Wang, A Vallée-Bélisle
Nature Methods 19 (1), 71-80, 2022
252022
The structural dynamics of engineered β-lactamases vary broadly on three timescales yet sustain native function
SMC Gobeil, MC Ebert, J Park, D Gagné, N Doucet, AM Berghuis, J Pleiss, ...
Scientific Reports 9 (1), 6656, 2019
242019
Substrate-specific screening for mutational hotspots using biased molecular dynamics simulations
MC Ebert, J Guzman Espinola, G Lamoureux, JN Pelletier
Acs Catalysis 7 (10), 6786-6797, 2017
232017
Indigo formation and rapid NADPH consumption provide robust prediction of raspberry ketone synthesis by engineered cytochrome P450 BM3
O Rousseau, MC Ebert, D Quaglia, A Fendri, AH Parisien, JN Besna, ...
ChemCatChem 12 (3), 837-845, 2020
202020
Evolution of P450 monooxygenases toward formation of transient channels and exclusion of nonproductive gases
MC Ebert, SL Dürr, A A. Houle, G Lamoureux, JN Pelletier
Acs Catalysis 6 (11), 7426-7437, 2016
172016
Dual-target inhibitors of the folate pathway inhibit intrinsically trimethoprim-resistant DfrB dihydrofolate reductases
JL Toulouse, G Shi, C Lemay-St-Denis, MC Ebert, D Deon, M Gagnon, ...
ACS medicinal chemistry letters 11 (11), 2261-2267, 2020
142020
Asymmetric mutations in the tetrameric R67 dihydrofolate reductase reveal high tolerance to active‐site substitutions
MC Ebert, KL Morley, JP Volpato, AR Schmitzer, JN Pelletier
Protein Science 24 (4), 495-507, 2015
132015
Structure-based design of dimeric bisbenzimidazole inhibitors to an emergent trimethoprim-resistant type II dihydrofolate reductase guides the design of monomeric analogues
JL Toulouse, BJ Yachnin, EH Ruediger, D Deon, M Gagnon, ...
ACS omega 4 (6), 10056-10069, 2019
122019
ATP synthase: a moonlighting enzyme with unprecedented functions
JN Vigneau, P Fahimi, M Ebert, Y Cheng, C Tannahill, P Muir, ...
Chemical Communications 58 (16), 2650-2653, 2022
112022
Novel crystallization conditions for tandem variant R67 DHFR yield a wild-type crystal structure
BJ Yachnin, DY Colin, JP Volpato, M Ebert, JN Pelletier, AM Berghuis
Structural Biology and Crystallization Communications 67 (11), 1316-1322, 2011
102011
Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents. Commun Biol 4: 1–10
V Mody, J Ho, S Wills, A Mawri, L Lawson, MC Ebert, GM Fortin, ...
82021
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20